Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.

Casas-Arozamena C, Díaz E, Moiola CP, Alonso-Alconada L, Ferreirós A, Abalo A, Gil CL, Oltra SS, de Santiago J, Cabrera S, Sampayo V, Bouso M, Arias E, Cueva J, Colas E, Vilar A, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L.

J Clin Med. 2020 Feb 21;9(2). pii: E585. doi: 10.3390/jcm9020585.

2.

Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.

Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, Matias-Guiu X, Lopez-Lopez R, Gil-Moreno A, Alonso-Alconada L, Abal M.

J Proteome Res. 2019 Mar 1;18(3):1043-1053. doi: 10.1021/acs.jproteome.8b00750. Epub 2019 Jan 11.

PMID:
30585730
3.

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

Devis L, Martinez-Garcia E, Moiola CP, Quiles MT, Arbos MA, Stirbat TV, Brochard-Wyart F, García Á, Alonso-Alconada L, Abal M, Diaz-Feijoo B, Thomas W, Dufour S, Mancebo G, Alameda F, Reventos J, Gil-Moreno A, Colas E.

Oncotarget. 2018 Mar 30;9(24):16648-16664. doi: 10.18632/oncotarget.24625. eCollection 2018 Mar 30.

4.

PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system.

Alonso-Alconada L, Barbazan J, Candamio S, Falco JL, Anton C, Martin-Saborido C, Fuster G, Sampedro M, Grande C, Lado R, Sampietro-Colom L, Crego E, Figueiras S, Leon-Mateos L, Lopez-Lopez R, Abal M.

Clin Transl Oncol. 2018 May;20(5):630-638. doi: 10.1007/s12094-017-1760-9. Epub 2017 Oct 20. Review.

PMID:
29058262
5.

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.

Insua YV, Cámara J, Vázquez EB, Fernández A, Rivera FV, Silva MJVV, Barbazán J, Muinelo-Romay L, Folgar SC, Abalo A, López-López R, Abal M, Alonso-Alconada L.

Int J Mol Sci. 2017 Jun 13;18(6). pii: E1265. doi: 10.3390/ijms18061265.

6.

Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.

Barbazán J, Alonso-Alconada L, Elkhatib N, Geraldo S, Gurchenkov V, Glentis A, van Niel G, Palmulli R, Fernández B, Viaño P, Garcia-Caballero T, López-López R, Abal M, Vignjevic DM.

Cancer Res. 2017 Jul 1;77(13):3431-3441. doi: 10.1158/0008-5472.CAN-16-1917. Epub 2017 May 23.

7.

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.

de la Fuente A, Alonso-Alconada L, Costa C, Cueva J, Garcia-Caballero T, Lopez-Lopez R, Abal M.

J Natl Cancer Inst. 2015 Jul 6;107(9). pii: djv184. doi: 10.1093/jnci/djv184. Print 2015 Sep.

8.

Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Pedrola N, Devis L, Llauradó M, Campoy I, Martinez-Garcia E, Garcia M, Muinelo-Romay L, Alonso-Alconada L, Abal M, Alameda F, Mancebo G, Carreras R, Castellví J, Cabrera S, Gil-Moreno A, Matias-Guiu X, Iovanna JL, Colas E, Reventós J, Ruiz A.

Clin Exp Metastasis. 2015 Jun;32(5):467-78. doi: 10.1007/s10585-015-9720-7. Epub 2015 Apr 30.

PMID:
25924802
9.

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.

Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D, Coenegrachts L, Cano A, Gil-Moreno A, Chiva L, Cueva J, Vieito M, Ortega E, Mariscal J, Colas E, Castellvi J, Cusido M, Dolcet X, Nijman HW, Bosse T, Green JA, Romano A, Reventos J, Lopez-Lopez R, Salvesen HB, Amant F, Matias-Guiu X, Moreno-Bueno G, Abal M; ENITEC Consortium.

Mol Cancer. 2014 Sep 27;13:223. doi: 10.1186/1476-4598-13-223.

10.

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.

Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M.

Carcinogenesis. 2014 Dec;35(12):2679-86. doi: 10.1093/carcin/bgu198. Epub 2014 Sep 18.

PMID:
25233929
11.

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

Alonso-Alconada L, Santacana M, Garcia-Sanz P, Muinelo-Romay L, Colas E, Mirantes C, Monge M, Cueva J, Oliva E, Soslow RA, Lopez MA, Palacios J, Prat J, Valls J, Krakstad C, Salvesen H, Gil-Moreno A, Lopez-Lopez R, Dolcet X, Moreno-Bueno G, Reventos J, Matias-Guiu X, Abal M.

Int J Cancer. 2015 Apr 15;136(8):1863-73. doi: 10.1002/ijc.29213. Epub 2014 Sep 29.

12.

Zoledronic acid as an antimetastatic agent for different human tumor cell lines.

Muinelo-Romay L, Garcia D, Alonso-Alconada L, Vieito M, Carmona M, Martínez N, Aguín S, Abal M, López-López R.

Anticancer Res. 2013 Dec;33(12):5295-300.

PMID:
24324062
13.

Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.

Barbazán J, Alonso-Alconada L, Muinelo-Romay L, Vieito M, Abalo A, Alonso-Nocelo M, Candamio S, Gallardo E, Fernández B, Abdulkader I, de Los Ángeles Casares M, Gómez-Tato A, López-López R, Abal M.

PLoS One. 2012;7(7):e40476. doi: 10.1371/journal.pone.0040476. Epub 2012 Jul 10.

14.

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer.

Barbazán J, Vieito M, Abalo A, Alonso-Alconada L, Muinelo-Romay L, Alonso-Nocelo M, León L, Candamio S, Gallardo E, Anido U, Doll A, de los Ángeles Casares M, Gómez-Tato A, Abal M, López-López R.

J Cell Mol Med. 2012 Oct;16(10):2342-9. doi: 10.1111/j.1582-4934.2012.01544.x.

15.

Tumor invasion and oxidative stress: biomarkers and therapeutic strategies.

Muinelo-Romay L, Alonso-Alconada L, Alonso-Nocelo M, Barbazan J, Abal M.

Curr Mol Med. 2012 Jul 1;12(6):746-62. Review.

PMID:
22292441
16.

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

Colas E, Muinelo-Romay L, Alonso-Alconada L, Llaurado M, Monge M, Barbazan J, Gonzalez M, Schoumacher M, Pedrola N, Ertekin T, Devis L, Ruiz A, Castellvi J, Doll A, Gil-Moreno A, Vazquez-Levin M, Lapyckyj L, Lopez-Lopez R, Robine S, Friederich E, Castro M, Reventos J, Vignjevic D, Abal M.

Oncogene. 2012 Nov 8;31(45):4778-88. doi: 10.1038/onc.2011.632. Epub 2012 Jan 23.

PMID:
22266854
17.

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.

Muinelo-Romay L, Colas E, Barbazan J, Alonso-Alconada L, Alonso-Nocelo M, Bouso M, Curiel T, Cueva J, Anido U, Forteza J, Gil-Moreno A, Reventos J, Lopez-Lopez R, Abal M.

Mol Cancer Ther. 2011 Aug;10(8):1357-66. doi: 10.1158/1535-7163.MCT-10-1019. Epub 2011 May 25.

Supplemental Content

Loading ...
Support Center